跳至主要内容
临床试验/NCT00477633
NCT00477633已完成3 期

An Open Label Study of the Contraceptive Efficacy of Norethindrone and Ethinyl Estradiol.

Warner Chilcott1 个研究点 分布在 1 个国家目标入组 1,700 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
1,700
试验地点
1
主要终点
Pearl Index, 18-35 Years, MITT Population

研究概览

简要总结

This is a non-comparative study. the primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy Women
  • Age 18-45
  • At risk for pregnancy
  • History of regular cycles

排除标准

  • Contraindications for use of hormonal contraception
  • Conditions which affect the absorption or metabolism of steroid hormones

研究组 & 干预措施

Norethindrone/ethinyl estradiol

Experimental

1 tablet per day

干预措施: Norethindrone/ethinyl estradiol (Drug)

结局指标

主要结局

Pearl Index, 18-35 Years, MITT Population

时间窗: 13 cycles (28 days each), approximately 364 days

Pregnancy rate in women 18-35 years old, Pearl Index - number of pregnancies per 100 women-years of treatment

次要结局

  • Mean Number of Days of Intracyclic Bleeding & Spotting, Cycles 2-13, MITT Population(12 cycles (28 days each), approximately 336 days)
  • Mean Median Duration (Days) of Intracyclic Bleeding & Spotting, Cycles 2-13, MITT Population(12 cycles (28 days each), approximately 336 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of Safety and Efficacy of an Oral Contraceptive | 临床试验